TOL.ST Net Margin

As of 2025-05-16, the Net Margin of Toleranzia AB (TOL.ST) is -5871.4%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

TOL.ST Net Margin - Historical Value

Date	Value
2022-12-31	-5871.4%
2021-12-31	-
2020-12-31	-
2019-12-31	-
2018-12-31	-
2017-12-31	-
2016-12-31	-
2015-12-31	-5871.4%
	-
	-

TOL.ST Net Margin - Peers Comparison

Ticker	Name	Value
ABNX.PA	Abionyx Pharma SA	-95.2%
ACTI.ST	Active Biotech AB publ	-479.5%
AEGIR.ST	Aegirbio AB	-64887%
ALLR.ST	Allarity Therapeutics A/S	-16473.8%
ALNEV.PA	Neovacs SA	-1639.2%
ALNOX.PA	Noxxon Pharma NV	-12954.2%
ALPAT.PA	Plant Advanced Technologies PAT SA	4.7%
ALPRE.PA	Predilife SA	-1329.2%
ALZ.ST	Alzinova AB	-68510%
BIOA B.ST	BioArctic AB	-68.8%
BIOG B.ST	Biogaia AB	24.7%
BONEX.ST	Bonesupport Holding AB	14.9%
COMBI.ST	Combigene AB	-13766.3%
EVG.L	Evgen Pharma PLC	-914.7%
GEN.WA	Genomed SA	4.8%
GKTX.PA	GenKyoTex SA	-
GUARD.ST	Guard Therapeutics International AB (publ)	-42397%
GV.PA	Genomic Vision SA	-661.8%
HNSA.ST	Hansa Biopharma AB	-471.2%
IDOGEN.ST	Idogen AB	-
IKM.MC	1nkemia IUCT Group SA	-1188.4%
IMMU.ST	Mendus AB (publ)	-7736.1%
ISR.ST	ISR Immune System Regulation Holding AB (publ)	-52301.1%
IVACC.ST	Intervacc AB	-640.7%
LIDDS.ST	Lidds AB	-1952.3%
MTPH.L	Midatech Pharma PLC	-944.6%
PROB.ST	Probi AB	2.7%
PROMO.ST	Promore Pharma AB	-148733.3%
RDG.WA	Read Gene SA	-7.8%
SCS.WA	Stem Cells Spin SA	-947%
SENZA.ST	SenzaGen AB	-30.9%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	14.9%
SPRINT.ST	Sprint Bioscience AB	-27.8%
VAL.L	ValiRx PLC	-21226%
VITR.ST	Vitrolife AB	14.2%
XBRANE.ST	Xbrane Biopharma AB	-134%
XINT.ST	Xintela AB	-929.8%